← Back to Search

Cell Therapy

Renal Autologous Cell Therapy (REACT) for Type 2 Diabetes

Phase 2
Waitlist Available
Research Sponsored by Prokidney
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 24 months following last nka injection
Awards & highlights

Study Summary

This trial is testing a new medication for people with AMD. The medication is given as two injections, six months apart. The study is assessing the safety and efficacy of the medication.

Eligible Conditions
  • Type 2 Diabetes
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 24 months following last nka injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 24 months following last nka injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Procedure and/or product related adverse events
Secondary outcome measures
Renal specific adverse events
Other outcome measures
Assess impact of NKA on eGFR
Assess impact of NKA on proteinuria
Assess impact of NKA on serum creatinine
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Renal Autologous Cell Therapy (REACT)Experimental Treatment1 Intervention
Renal Autologous Cell Therapy (REACT) Treatment - Patients will receive their first treatment of 2 injections of REACT as soon as REACT product is made available.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Renal Autologous Cell Therapy (REACT)
2016
Completed Phase 2
~100

Find a Location

Who is running the clinical trial?

ProkidneyLead Sponsor
8 Previous Clinical Trials
1,433 Total Patients Enrolled
CTI Clinical Trial and Consulting ServicesOTHER
34 Previous Clinical Trials
3,725 Total Patients Enrolled
Ashley JohnsStudy DirectorProkidney
5 Previous Clinical Trials
1,342 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
65+
What site did they apply to?
University of Arizona
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease
2018. "A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03270956.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top